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Fig. S1. Concentration-response relationship of HmK blockade of KcsA-Shaker.
Inhibition of peptide HmK (•) on KcsA-Shaker was studied by TEVC as described in Materials and Methods and fit to the Hill relationship (Eqn 1). The Ki of peptide HmK for KcsA-Shaker channels was estimated from the fit to be 0.94 ± 0.08 nM with a Hill coefficient of 1.03 ± 0.09. n = 6 for each condition. Values are mean ± SEM. Error bars are smaller than symbols.
Fig. S2. Effect of mutation
KcsA-Shaker-Y82V on block by TEA and HmK. KcsA-Shaker-Y82V were expressed in oocytes and studied by TEVC to assess equilibrium inhibition using a holding voltage of −80 mV, 300 ms test pulses to 0 mV, and a 5 s interpulse interval. (A) Representative current trace for KcsA-Shaker-Y82V with 50 mM TEA (red) or without TEA application (black). (B) Representative current trace for KcsA-Shaker-Y82V with 500 nM peptide HmK (red) or without peptide application (black). HmK 3D structure adopts a typical SAK1 helix-kink-helix conformation, with residues 14-18 and 22-26 forming two short perpendicular α-helices. Side chains residues Met21-Lys22-Tyr23-Arg24 of ShK and HmK (Met20-Lys21-Tyr22-Arg23 of Hui1) are noted. HmK (blue, this work, PDB 6EI7); Hui1 (2N6B, orange); and ShK (4LFQ, grey). S1. Single-particle counting and calculation of effective T-HmK surface concentration. As described in Materials and Methods, T-RFP and T-HmK were expressed in Xenopus oocytes by injection of cRNA; single fluorescent particles in 100 µm 2 (n) were counted by smTIRF microscopy; simultaneous photobleaching revealed that all particles contained only one T-RFP (n = 170); average number of T-RFP peptides on the surface of oocytes (N) was estimated based on average surface area; and because the relative surface expression of T-RFP and T-HmK were consistently related (Fig. 1H) , the effective concentration of T-HmK could be estimated from the counted number of T-RFP ( Fig. 1F ) and the measured T-HmK by ELISA (Fig. 1, G and H) . With 0.5 ng cRNA injection, the effective concentration of T-HmK is estimated to be 17 ± 2 nM and the Ki of T-HmK block of KcsA-Shaker to be 1.1 ± 0.1 nM, according to Eqn 1. The calculated concentrations of T-HmK with 0.35 and 1 ng cRNA estimated by electrophysiology (Fun) are similar to those estimated by ELISA and smTIRF. Table S3 . Blocking parameters of hKv1.3 by T-HmK, T-ShK, and the analogous free peptide variants. hKv1.3 inhibition at equilibrium (Ki ± SEM) was determined as described in Figs. 1 and 2 ; the kinetic parameters were assessed at 0 mV; n = 16-18 oocytes for T-toxins, and n = 6 oocytes for peptides.
T-toxin expressed with or without KcsA-Shaker channels T-HmK T-RFP T-RFP / T-HmK
Toxins K i (nM) k on (1/Ms) k off (1/s) T-HmK 3.0 ± 0.4 5.4 × 10 6 ± 0.8 × 10 6 1.6 × 10 -2 ± 0.2 × 10 -3 T-HmK-Lys 22 Asn 702 ± 88 1.4 × 10 6 ± 0.2 × 10 6 9.3 × 10 -1 ± 1.2 × 10 -1 T-HmK-Arg 24 Gln 8.1 ± 1.0 5.3 × 10 6 ± 0.8 × 10 6 4.3 × 10 -2 ± 0.6 × 10 -3 T-ShK 0.098 ± 0.012 1.2 × 10 8 ± 0.2 × 10 8 1.2 × 10 -2 ± 0.2 × 10 -2 T-ShK-Lys 22 Asn 0.42 ± 0.05 7.2 × 10 7 ± 0.7 × 10 7 3.1 × 10 -2 ± 0.4 × 10 -2 T-ShK-Arg 24 Gln 0.075 ± 0.010 9.9 × 10 7 ± 1.3 × 10 7 7.4 × 10 -3 ± 0.8 × 10 -3
Peptide HmK 3.1 ± 0.2 1.1 × 10 6 ± 0.1 × 10 6 3.4 × 10 -3 ± 0.2 × 10 -3
Peptide HmK-Lys 22 Asn 2225 ± 238 3.0 × 10 5 ± 0.4 × 10 5 6.7 × 10 -1 ± 0.8 × 10 -1 Peptide ShK 0.05 ± 0.01 2.7 × 10 7 ± 0.4 × 10 7 1.3 × 10 -3 ± 0.1 × 10 -3
Peptide ShK-Lys 22 Asn 1.2 ± 0.1 0.8 × 10 7 ± 0.1 × 10 7 9.6 × 10 -3 ± 0.9 × 10 -3
Peptide ShK-Arg 24 Gln 0.034 ± 0.006 2.4 × 10 7 ± 0.3 × 10 7 0.8 × 10 -3 ± 0.1 × 10 -3 
